AzTrials
AzTrials

Language Development DisordersMEMENTONCT02609542

Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder

An observational study of Language Development Disorders, run by Lille Catholic University at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The disorder of oral language development is defined by the delay in language acquisition in children who possess efficient auditory acuity and normal non verbal intellect. The diversity of language developement disorders depends either in the expressive level or in the receptive level leading to divers syndromes and… Read more about this study

Who is it for?
Ages 45 to 95 monthsHealthy volunteers can take part
Conditions the study is for
Language Development Disorders
What is being tested?
Eye Tracking
How many people
173 participants
Where
1 siteFrance
Study dates
Mar 2014to May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 95 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: STOL children between 45 and 95 months of age at inclusion recruited at the neuropediatric consultation and control children of the same age recruited at schools

Who may be able to join

  • Child aged between 45 and 95 months at inclusion
  • A score > or equal to 5 percentile on the non verbal intelligence test (PM47)
  • Patient diagnosed with STOL by the neuropediatric medical team
  • Coverage of the social insurance
  • Consent form signed by the parents or the legal representative of the child
  • Normal or corrected sight
Show all 14Show fewer
  • Normal hearing
  • Child aged between 45 and 95 months on the day of inclusion
  • A score > or equal to 5 percentile on the non verbal intelligence test (PM47)
  • Child who did not receive any speech therapy
  • Coverage of the social insurance
  • Consent form signed by the parents or the legal representative of the child
  • Normal or corrected sight
  • Normal hearing

Who cannot join

  • Mother language other than French
  • Score < to 5 percentile on the non verbal intelligence test (PM47)
  • Child with pervasive developmental disorder
  • Mother language other than French
  • Score < to 5 percentile on the non verbal intelligence test (PM47)
  • Child who received speech therapy

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital St Vincent-de-Paul (GHICL)

    Lille, Hauts-de-France, 59000

Other trials in France

About this study

Official title: Coding and Memorisation of Phonologic Information Among Preschool and School Children With Oral Language Developement Disorder.

The disorder of oral language development is defined by the delay in language acquisition in children who possess efficient auditory acuity and normal non verbal intellect.

The diversity of language developement disorders depends either in the expressive level or in the receptive level leading to divers syndromes and symptoms. These syndromes and symptoms are regrouped under the name of STOL (Specific Troubles of Oral Language).

In the current project the visual exploitation and learning capability of children presenting a STOL condition will be compared to patients with a normal development. The investigator's hypothesis is as follows: STOL patients for whom the STOL disorder is reduced between 4 and 7 years of age will present a better performance at verbal memorisation, compared to patients with a persistent STOL condition after the age of 6.

Being tested
Eye Tracking
Keywords
oral language, STOL, memory, eye tracking
Medical subject headings
Language Development Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye TrackingOther

    Also called visual world paradigm

    Eye tracker will allows the recording of various information concerning eye fixation (number, duration, location) and saccadic eye movement (speed, range, number, duration) in order to determine the interplay between linguistic and visual information processing during tests performance

Study groups in NCT02609542
Study groupRoleWhat they receive
STOL groupSTOL children will be recruited in the neuropediatric unit at the GHICL in Lille. Children will be followed and we will determine if capacities of verbal memory of the children presenting STOL diagnosed at an early stage of their development (before 6 years) are predictive of the evolution of the disorder according to their cognitive profile and more specifically, their language profile as well as their tests performances. The participants' eye movements ( visual world paradigm or eye tracking) will be recorded in order to determine the interplay between linguistic and visual information processing. Patients with a persistent STOL will be identified at the end of the follow up.
Receives: Other: Eye Tracking
Control groupChildren with no language development disorder willing to participate in the study will be recruited at school. The participants' eye movements ( visual world paradigm or eye tracking) will be recorded in order to determine the interplay between linguistic and visual information processing.
Receives: Other: Eye Tracking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from baseline in the score associated to speech-language outcome measured by a scale grouping results of different questionnaires

    We will determine if capacities of verbal memory of the children presenting STOL diagnosed at an early stage of their development (before 6 years) are predictive of the evolution of the disorder according to their cognitive profile and more specifically, their language profile as well as their tests performances. To measure the speech language outcome is necessary to take in consideration the score of more than one test performance.

    Measured: 0,12, 24 months

Secondary outcomes (6)
  1. Changes from baseline in the Raven's Progressive Matrices (RPM) test

    Raven's Progressive Matrices (RPM) is a test often used in educational settings that is comprised of 60 multiple choice questions. This is a nonverbal test in that the questions are comprised of visual patterns. RPM measures the ability to think clearly about complex ideas and the ability to store and recall information.

    Measured: 0,12, 24 months

  2. Changes from baseline in the Peabody Picture Vocabulary Test

    The Peabody Picture Vocabulary Test measures an individual's receptive (hearing) vocabulary and provides, at the same time, a quick estimate of verbal ability or scholastic aptitude.

    Measured: 0,12, 24 months

  3. Changes from baseline in the number repetition test

    Measured: 0,12, 24 months

  4. Changes from baseline in the sentences repetition test

    Measured: 0,12, 24 months

  5. Changes from baseline in the non-words repetition test

    Measured: 0,12, 24 months

  6. Changes from baseline in the children's eye tracking

    It is done in order to determine if their is a relation between the evolution of processes involved in verbal memorisation (cognitive mechanisms in charge of data processing).

    Eye tracker will allow the recording of information regarding eye fixation (number, duration, location) and saccadic eye movements (speed, range, number, duration) in order to determine the interplay between linguistic and visual information processing during test performances.

    Measured: 0,12, 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2015 (estimated)
  2. Study startMar 2014
  3. Primary completionMay 2023
  4. Study completionMay 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
173 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02609542
Sponsor's protocol ID
RC-P0029
Acronym
MEMENTO
Status last verified
Nov 2025
First submitted
4 Aug 2015
Last updated
4 Dec 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Language Development Disorders, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from baseline in the score associated to speech-language outcome measured by a scale grouping results of different questionnaires (time frame: 0,12, 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in